← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

Increased

Reduced

Net increased

Funds Holding 3,173

Funds Holding Change -24

Funds Holding Growth -0.8%

Value $530B

Holding in Top 10 323

Top 10 Change -102

Top 10 Growth -24%

Value Growth -6%

New 113

Increased 1,340

Reduced 1,482

Closed 103

Capital Inflow $15.3B

Capital Outflow $22.6B

Net Capital Flow -$7.29B

Capital Flow Change -$3.81B

Calls $4.64B

Puts $5.73B

Net Calls -$1.08B

Put/Call Ratio 1.23